Efficacy and imaging evaluation of 177Lu-labeled antibody-drug conjugates as a potential theranostic agent for HER2-positive breast cancer

被引：0
|
作者：
Kim, Heejung [1 ]
Shin, Eunbi [1 ]
Lee, JooHyun [1 ]
Yoo, Ran Ji [1 ]
Park, Jang Woo [1 ]
Chung, Hye Kyung [1 ]
Shim, Jae-Hoon [1 ]
机构：
[1] Korea Inst Radiol & Med Sci KIRAMS, Seoul, South Korea
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2021年 / 96-97卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
SP-124
引用
收藏
页码：S104 / S105
页数：2
相关论文
共 50 条
  • [1] Antibody-drug conjugates in HER2-positive breast cancer
    Li Lixi
    Zhang Di
    Liu Binliang
    Lv Dan
    Zhai Jingtong
    Guan Xiuwen
    Yi Zongbi
    Ma Fei
    中华医学杂志英文版, 2022, 135 (03) : 261 - 267
  • [2] Antibody-drug conjugates in HER2-positive breast cancer
    Li, Lixi
    Zhang, Di
    Liu, Binliang
    Lv, Dan
    Zhai, Jingtong
    Guan, Xiuwen
    Yi, Zongbi
    Ma, Fei
    CHINESE MEDICAL JOURNAL, 2022, 135 (03) : 261 - 267
  • [3] New antibody-drug conjugates for HER2-positive breast cancer
    Gourd, Katherine
    LANCET ONCOLOGY, 2020, 21 (01): : 28 - 28
  • [4] Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer
    Najjar, Mariana K.
    Manore, Sara G.
    Regua, Angelina T.
    Lo, Hui-Wen
    GENES, 2022, 13 (11)
  • [5] Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer
    Yu, Yongchao
    Wang, Jin
    Liao, Dongying
    Zhang, Dou
    Li, Xiaojiang
    Jia, Yingjie
    Kong, Fanming
    BREAST CANCER-TARGETS AND THERAPY, 2022, 14 : 417 - 432
  • [6] Preliminary study of 177Lu-labeled Herceptin as theranostic agent of HER2-positive human lung adenocarcinoma xenografts in mice
    Wang, Tao
    Peng, Ye
    Li, Xiao
    Li, Danni
    Zuo, Changjing
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [7] "Antibody Engineering" and Antibody-drug Conjugates for new Therapeutic Options in metastatic HER2-positive Breast Cancer
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (06)
  • [8] AN ANTIBODY-DRUG CONJUGATE IS EFFECTIVE IN HER2-POSITIVE BREAST CANCER
    不详
    CANCER DISCOVERY, 2012, 2 (11) : 969 - 969
  • [9] Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells
    Chiang, Zu-Chian
    Chiu, Yi-Kai
    Lee, Cheng-Chung
    Hsu, Nai-Shu
    Tsou, Yueh-Liang
    Chen, Hong-Sen
    Hsu, Horng-Ru
    Yang, Tzung-Jie
    Yang, An-Suei
    Wang, Andrew H-J
    PLOS ONE, 2020, 15 (09):
  • [10] Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directions
    Emanuela Ferraro
    Joshua Z. Drago
    Shanu Modi
    Breast Cancer Research, 23
12345